Tonix Pharmaceuticals Announces Appointment of Sina Bavari,

CHATHAM, N.J., July 25, 2022 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage...

Related Keywords

Los Angeles ,Jessica Morris ,Sina Bavari ,Seth Lederman ,Olipriya Das ,Peter Vozzo ,Bacteriology Division ,Tonix Pharmaceuticals ,University Of Nebraska Medical Center ,University Of Southern California ,Nasdaq ,Nuclear Physics ,Tonix Pharmaceuticals Holding Corp ,Translational Research ,Tonix Infectious Disease Rd Center ,Nuclear Pharmacy ,Development Center ,Toxicology Division ,Infectious Disease Research ,Exchange Commission ,Translational Sciences Division ,Therapeutic Discovery Center ,Pharmaceuticals Holding ,Executive Vice President ,Infectious Disease Rd Center ,Chief Executive Officer ,Investigational New Drug ,Chief Scientific Officer ,Scientific Director ,Research Institute ,Infectious Diseases ,Target Discovery ,Experimental Microbiology ,Integrated Toxicology Division ,Target Identification ,Pharmaceutical Science ,Nebraska Medical Center ,Southern California ,Breakthrough Therapy Designation ,Orphan Drug Designation ,Private Securities Litigation Reform Act ,Annual Report ,Nasdaq Tnxp ,